Therapeutic Efficacy of YH35324 on FcεRIα-Mediated Mast Cell/Basophil Activation

Min Sook Ryu(Ajou University), Hae‐Sim Park(Princeton University)

Allergy Asthma and Immunology Research

January 1, 2025

10.4168/aair.2025.17.2.181

Cited by 7

Related Papers

The<i>Swift</i>Gamma‐Ray Burst Mission

|The Astrophysical Journal|2004|4.2k

Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines—2016 revision

|Journal of Allergy and Clinical Immunology|2017|2k

2015 update of the evidence base: World Allergy Organization anaphylaxis guidelines

|World Allergy Organization Journal|2015|588

Efficacy and safety of treatment with biologicals (benralizumab, dupilumab, mepolizumab, omalizumab and reslizumab) for severe eosinophilic asthma. A systematic review for the EAACI Guidelines ‐ recommendations on the use of biologicals in severe asthma

|Allergy|2020|406

EAACI Biologicals Guidelines—Recommendations for severe asthma

|Allergy|2020|275